Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-5-5
pubmed:abstractText
Adjuvant therapy for Stage II colon cancer remains controversial but may be considered for patients with high-risk features. The purpose of this study was to assess the prognostic significance of commonly reported clinicopathologic features of Stage II colon cancer to identify high-risk patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1530-0358
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-7
pubmed:meshHeading
pubmed-meshheading:18322753-Adenocarcinoma, pubmed-meshheading:18322753-Aged, pubmed-meshheading:18322753-Aged, 80 and over, pubmed-meshheading:18322753-Chemotherapy, Adjuvant, pubmed-meshheading:18322753-Chi-Square Distribution, pubmed-meshheading:18322753-Colonic Neoplasms, pubmed-meshheading:18322753-Colonoscopy, pubmed-meshheading:18322753-Female, pubmed-meshheading:18322753-Humans, pubmed-meshheading:18322753-Male, pubmed-meshheading:18322753-Neoplasm Recurrence, Local, pubmed-meshheading:18322753-Neoplasm Staging, pubmed-meshheading:18322753-Patient Selection, pubmed-meshheading:18322753-Prognosis, pubmed-meshheading:18322753-Proportional Hazards Models, pubmed-meshheading:18322753-Prospective Studies, pubmed-meshheading:18322753-Survival Rate, pubmed-meshheading:18322753-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
pubmed:affiliation
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
pubmed:publicationType
Journal Article